Protocol treatment of anemia with iron in elderly patients undergoing hip fracture

• Conditions: Hip fracture; MedDRA version: 18.0Level: PTClassification code 10020100Term: Hip fractureSystem Organ Class: 10022117 - Injury, poisoning and procedural complications; Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]

• Registration Number: EUCTR2014-001923-53-ES
• Lead Sponsor: Rafael Bielza Galindo

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2015-07-10
• Last Update Posted: 12 October 2015

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Patients included in the study with hip fracture
osteoporotic treated in our unit, with the following characteristics:
• Age over 75 years
• Having borrowed agreed to participate in the study by signing the
corresponding Informed Consent Document.
 

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 200

Exclusion Criteria

• Hypersensitivity to oral or parenteral preparations of iron.
• Asthma or other severe atopy.
• Withdrawal of informed consent.
• No indication of surgical fracture

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified